포스데비린

Fosdevirine
포스데비린
Fosdevirine.svg
임상자료
기타 이름GSK2248761; GSK2248761A; IDX-12899; IDX-899
ATC 코드
  • 없음
식별자
  • 5-Cloro-3-[3-[(E)-2-cyanoethenyl]-5-methylphylfhenyl]-methoxyphosphoryl]-1H-indole-2-carboxamide
CAS 번호
펍켐 CID
유니
화학 및 물리적 데이터
공식C20H17CLN3O3P
어금질량413.80 g·190−1
3D 모델(JSmol)
  • CC1=CC(=CC(=C1)/C=C/C#N)[P@]=C2=C(NC3=C2C=C2C(C=C3)Cl(=O)N)OC
  • InChI=1S/C20H17ClN3O3P/c1-12-8-13(4-3-7-22)10-15(9-12)28(26,27-2)19-16-11-14(21)5-6-17(16)24-18(19)20(23)25/h3-6,8-11,24H,1-2H3,(H2,23,25)/b4-3+/t28-/m1/s1
  • 키:CGBYTKOSZYQOPV-ASSBYYIWSA-N

Fosdevirine은 HIV-AIDS 치료에 잠재적인 사용을 위해 연구된 비뉴클레오사이드 역분해효소 억제제 클래스의 실험 항바이러스제다.[1][2]

아이데닉스제약이 발굴해 글락소스미스클라인ViV헬스케어가 개발 중이었으나 예상치 못한 부작용 때문에 현재는 단종됐다[3][4].[5]

참조

  1. ^ Dousson C, Alexandre FR, Amador A, Bonaric S, Bot S, Caillet C, et al. (March 2016). "Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor". Journal of Medicinal Chemistry. 59 (5): 1891–8. doi:10.1021/acs.jmedchem.5b01430. PMID 26804933.
  2. ^ "Fosdevirine". AIDSinfo. U.S. National Library of Medicine, U.S. Department of Health and Human Services.
  3. ^ "Fosdevirine". Adis Insight. Springer Nature Switzerland AG. Highest Development Phases: Discontinued, HIV-1 infections
  4. ^ "Fosdevirine". MedKoo Biosciences. GSK2248761 is no longer in clinical development.
  5. ^ Margolis DA, Eron JJ, DeJesus E, White S, Wannamaker P, Stancil B, Johnson M (2013). "Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761)". Antiviral Therapy. 19 (1): 69–78. doi:10.3851/IMP2689. PMID 24158593.